Drug Type siRNA |
Synonyms- |
Target |
Action inhibitors |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Ductal Adenocarcinoma | Preclinical | Germany | - | |
Colorectal Cancer | Discovery | Germany | 11 Jun 2024 | |
Non-Small Cell Lung Cancer | Discovery | Germany | 11 Jun 2024 |